Search filters

List of works by Tomasz M Beer

A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma

scientific article published on June 2011

A New Formulation of Calcitriol (DN-101) for High-Dose Pulse Administration in Prostate Cancer Therapy

scientific article published on 01 January 2003

A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer

scientific article published in September 2003

A molecular correlate to the Gleason grading system for prostate adenocarcinoma

scholarly article

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

scientific article

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

scientific article

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer

scientific article published on 22 October 2014

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

scientific article published on 13 June 2019

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

scientific article published on 01 July 2020

A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinoma

scientific article published on 10 December 2009

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

scientific article

A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy

scientific article published in April 2010

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

scientific article

Abstract 731: Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer

article

Abstract A12: Identification of pathways associated with abiraterone resistance in metastatic castration resistant prostate cancer: Preliminary results from the SU2C/AACR West Coast Prostate Cancer Dream Team

article

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations

scientific article published on 01 October 2020

Acupuncture for hot flashes in patients with prostate cancer

scientific article

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study

scientific article published on 01 May 2007

American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer

scientific article published on 09 October 2007

Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors

scientific article published on 27 April 2017

Androgen deprivation impairs memory in older men.

scientific article published on December 2005

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer

scientific article published on 13 March 2017

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

scientific article

Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy

scientific article published on May 2007

Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials

scientific article published on 12 December 2019

Association of codon 72 polymorphism of p53 with lower prostate cancer risk

scientific article published on 01 December 2001

Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer

scientific article

Autoantibody landscape in patients with advanced prostate cancer

scientific article published on 23 September 2020

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer

scientific article published on 4 November 2015

Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the Exercising Together project

scientific article published on 29 December 2015

Bevicizumab and thrombosis: some answers but questions remain

scientific article published on 21 November 2014

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial

scientific article published on June 2008

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results

scientific article

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity

scientific article published on March 2010

CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield

scientific article published on 24 May 2017

Calcitriol in the treatment of prostate cancer

scientific article

Carbohydrate-conjugated fluorescent silica nanoprobes for selective detection of galectin-1 and prostate cancer cells

scientific article published on January 2015

Cell membrane water exchange effects in prostate DCE-MRI.

scientific article

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.

scientific article published on 03 June 2016

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

scientific article

Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy

scientific article published on 01 March 2006

Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo

scientific article published on 20 July 2017

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

scientific article published on 09 July 2018

Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer

scientific article published on September 2005

Combining options in metastatic prostate cancer

scientific article published on 01 October 2019

Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future research

scientific article published on February 2013

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.

scientific article published in December 2017

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 29 July 2020

Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

scientific article published on 01 April 2019

Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, internation

scientific article published on 9 October 2017

Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo.

scientific article

DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer

article

Darbepoetin alfa administered every 4 weeks for anemia in patients with advanced prostate cancer

scientific article published on 01 June 2007

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

scientific article

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

scientific article

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

scientific article published on 01 November 2018

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

scientific article

Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

scientific article published on 01 September 2007

Docetaxel (taxotere) in the treatment of prostate cancer

scientific article

Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates.

scientific article published on 23 September 2016

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

scientific article published on 01 February 2007

Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer

scientific article published on 02 July 2020

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.

scientific article published on 12 July 2016

Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial

scientific article published on 15 November 2018

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial

scientific article

Effect of calcitriol on prostate-specific antigen in vitro and in humans.

scientific article published on May 2006

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomi

scientific article published on 14 April 2015

Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer

scientific article

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial.

scientific article published on 20 September 2016

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

scientific article

Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trial.

scientific article published on 27 March 2016

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

scientific article published on 28 July 2016

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

scientific article published on 01 October 2014

Enzalutamide in metastatic prostate cancer before chemotherapy

scientific article published in June 2014

Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

scientific article published on 17 September 2018

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

scientific article published on 16 August 2018

Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy

scientific article published on 6 March 2017

Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial

scientific article published on 31 December 2020

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

scientific article published on 27 March 2012

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

scientific article published on 15 August 2020

Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial

scientific article published on 09 June 2020

Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.

scientific article

Genetic polymorphisms in head and neck cancer risk

scientific article published on 01 September 2000

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.

scientific article

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

scientific article published on 28 March 2019

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

scientific article published on 18 April 2019

Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer

scientific article published on 19 November 2019

HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia.

scientific article published on 14 September 2011

HIF1α protein stability is increased by acetylation at lysine 709.

scientific article

Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc): An In-Depth Analysis Of Eq-5d Data From The Prevail Trial

scientific article published on 20 October 2015

Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial

scientific article

High dose calcitriol may reduce thrombosis in cancer patients

scientific article published on 19 September 2006

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study

scientific article (publication date: September 2005)

High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer

scientific article published on 3 June 2017

High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancer

scientific article published in October 2004

High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma

scientific article published in March 2003

Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer.

scientific article

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

scientific article published in September 2004

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

scientific article published on 13 April 2010

Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.

scientific article published on 15 May 2015

Implementing a comprehensive translational oncology platform: from molecular testing to actionability

scientific article published on 14 December 2018

Improved detection of prostate cancer using classification and regression tree analysis

scientific article published on 21 March 2005

In Reply

article published in 2008

In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors

scientific article

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

article

Interest in physician-assisted suicide among Oregon cancer patients

scientific article published in January 2006

Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel

scientific article published on 9 December 2014

Intermittent chemotherapy in metastatic androgen-independent prostate cancer

scientific article published on September 2003

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel

scientific article published in January 2008

Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

scientific article published in Nature Communications

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

scientific article published on 27 March 2013

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

scientific article published on 13 May 2014

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium

scientific article published on 29 December 2010

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.

scientific article published on 26 March 2018

Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy

scientific article published on 01 July 2007

Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer

scientific article published on 16 February 2015

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

scientific article published on 25 February 2019

Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.

scientific article published on 06 February 2013

Management of Anticoagulation in Patients With Prostate Cancer Receiving Enzalutamide

scientific article published in November 2017

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

scientific article published on 02 May 2016

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

scientific article published on 3 June 2015

Metastatic adenocarcinoma of prostate in a healing sternotomy site

scientific article

Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making

scientific article published on 28 June 2017

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.

scientific article published in October 2007

Molecular pathways and targets in prostate cancer

scientific article

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer

scientific article published on October 2004

Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer

scientific article published on 01 May 2006

New therapies for castration-resistant prostate cancer: efficacy and safety

scientific article published on 04 May 2011

Novel cytotoxic and biological agents for prostate cancer: where will the money be in 2005?

scientific article

Optimal timing of chemotherapy in androgen independent prostate cancer

scientific article published on January 2009

Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?

scientific article

Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer

scientific article published on October 2008

Patterns and predictors of symptom incongruence in older couples coping with prostate cancer

scientific article published on 17 December 2013

Personalizing prostate cancer therapy: the way forward

scientific article

Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer

scientific article published in November 2005

Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: focus on non-chemotherapy agents

scientific article

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.

scientific article

Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consort

scientific article

Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer

scientific article published on 26 October 2006

Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer

scientific article published in February 2004

Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy

scientific article published on 07 August 2020

Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel

scientific article published on 07 July 2007

Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy

scientific article published in May 2003

Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer

scientific article

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

scientific article

Phase II study of transdermal estradiol in androgen-independent prostate carcinoma

scientific article published in February 2005

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

scientific article published on September 2001

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.

scientific article published on 11 May 2017

Polymorphisms of GSTT1 and related genes in head and neck cancer risk.

scientific article published in January 2004

Pooled analysis of C-reactive protein levels and mortality in prostate cancer patients

journal article published in 2015

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.

scientific article

Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC

scientific article published on 28 September 2020

Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer

scientific article published in August 2017

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL ⬇️

scientific article published on October 1, 2003

Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigen

scientific article published on 01 January 2004

Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study

scientific article published on April 2007

Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.

scientific article published on 25 June 2013

Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study

article

Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial

scientific article published on 03 December 2018

Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894

scientific article published on 01 December 2004

Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation

scientific article published on 22 December 2015

Prolonged response to early docetaxel in a patient with biochemical relapse after primary therapy for prostate cancer and incomplete response to androgen suppression therapy

scientific article published on March 1, 2011

Prostate cancer and vitamin D: what does the evidence really suggest?

scientific article published on 14 June 2011

Prostate cancer-associated gene expression alterations determined from needle biopsies

scientific article

Prostate specific antigen only androgen independent prostate cancer: natural history, challenges in management and clinical trial design

scientific article published on 20 July 2007

Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer

scientific article published in April 2005

Publisher Correction: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

scientific article published in Nature Communications

Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer

scientific article published in August 2013

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma

scientific article

Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial

scientific article published on 8 March 2018

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.

scientific article

Raising the Bar for Therapeutic Trials in Advanced Prostate Cancer

scientific article published on 11 July 2016

Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy

scientific article published in December 2004

Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer

scientific article published on 10 May 2011

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

scientific article published on 31 October 2016

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer

scientific article

Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies

scientific article published on November 2005

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs

scientific article published on 19 December 2018

Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer

scientific article

Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer

scientific article

Resistance of prostate cancer cell lines to COX-2 inhibitor treatment

scientific article

Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial

scientific article published on 3 September 2014

Review of exercise studies in prostate cancer survivors receiving androgen deprivation therapy calls for an aggressive research agenda to generate high-quality evidence and guidance for exercise as standard of care

article

Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer

scientific article

Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer ⬇️

scientific article published on March 13, 2003

Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.

scientific article published on January 2014

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.

scientific article published on 10 April 2010

Serum and dietary vitamin D and cardiovascular disease risk in elderly men: A prospective cohort study ⬇️

scientific article published on April 3, 2011

Should Chemotherapy Be Used in Nonmetastatic Prostate Cancer?

scientific article

Should docetaxel be administered earlier in prostate cancer therapy?

scientific article

Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma

scientific article published on 28 September 2013

Skeletal response to resistance and impact training in prostate cancer survivors

scientific article

Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC).

scientific article

Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials

scientific article

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group

scientific article published on August 2007

Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies

scientific article

Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy

scientific article published in March 2008

Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes

scientific article published on September 2008

Statins and prostate cancer risk: a case-control study

scientific article

Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel

scientific article published in January 2002

Targeted therapy in prostate cancer: is there hope beyond the androgen receptor?

scientific article

Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer: Update on the Stand Up 2 Cancer/Prostate Cancer Foundation-Supported West Coast Prostate Cancer Dream Team

scientific article

Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy

scientific article published in February 2004

Testosterone loss and estradiol administration modify memory in men.

scientific article published in January 2006

The DNA methylation landscape of advanced prostate cancer

scientific article published on 13 July 2020

The Exercising Together project: design and recruitment for a randomized, controlled trial to determine the benefits of partnered strength training for couples coping with prostate cancer

scientific article published on 11 November 2011

The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials ⬇️

journal article from 'Cancers' published in 2021

The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

scientific article published on 19 March 2016

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

scientific article published on 20 December 2016

The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies

scientific article published on 30 October 2017

The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study

scientific article published on January 2009

The effects of partnered exercise on physical intimacy in couples coping with prostate cancer

scientific article published on 12 October 2015

The hazards of intermediate endpoints

scientific article published on 01 November 2007

The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells

scientific article

The medical management of prostate cancer: a multidisciplinary team approach.

scientific article published on 6 September 2006

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894

scientific article published on 01 August 2006

The role of C-reactive protein in prostate cancer

scientific article published in July 2013

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

scientific article

Toward predictors of survival in castration-resistant prostate cancer

scientific article published on 09 March 2011

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

scientific article published on 18 May 2020

Treatment of Nonmetastatic Castration-Resistant Prostate Cancer

scientific article

Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study

scientific article published in August 2005

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.

scientific article

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer ⬇️

scientific article published on August 31, 2010

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

scientific article published on 6 March 2014

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

scientific article published on 07 January 2020

Views on physician-assisted suicide among family members of Oregon cancer patients

scientific article published on 01 September 2006

Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 years

scientific article published in December 2003

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer ⬇️

scientific article published on August 1, 2001

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

scientific article

Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity

scientific article published on 27 March 2019

Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer

scientific article published in September 2006

Paulina is supported by:

About Paulina

Help